GLP-3(R).

GLP-3 is a retatrutide-class GLP-1/GIP/glucagon triple receptor agonist research peptide with the molecular formula C₂₂₁H₃₄₂N₄₆O₆₈ and a molecular weight of 4731.33 g/mol (CAS: 2381089-83-2), studied...

$43.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for GLP-3(R).

GLP-1R/GIPR/GCGR simultaneous activation

Triple Receptor Co-Agonism

GLP-3 activates three incretin/glucagon receptors concurrently, engaging distinct cAMP pathways in beta-cell and adipocyte culture models.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on GLP-3(R) molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of GLP-3(R) in standardized assay systems.

Preclinical

GLP-3(R) structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of GLP-3(R) in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring